Lv6
1670 积分 2024-06-26 加入
One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma
1天前
待确认
Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK1 receptor antagonists
11天前
已完结
Substance P and CGRP do not play an important role in TNFα-induced inflammation
11天前
已完结
Amylin Analog Pramlintide Induces Migraine‐like Attacks in Patients
11天前
已完结
Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP success
11天前
已完结
Effects of substance P on headache induction and arterial dilation in healthy adults
12天前
已完结
2025 Highlights in new targets for migraine treatment
21天前
已完结
Exploring plasticisers-osteoporosis links and mechanisms: a cohort and network toxicology study
1个月前
已完结
Mammalian Transient Receptor Potential (TRP) Cation Channels
1个月前
已完结
Preclinical and clinical evaluation of a novel TRPA1 antagonist LY3526318
1个月前
已完结
皖公网安备34019202002308
